Innovent Biologics Inc
Change company Symbol lookup
Select an option...
IVBXF Innovent Biologics Inc
STEM Stem Inc
ZIM ZIM Integrated Shipping Services Ltd
METC Ramaco Resources Inc
NVTS Navitas Semiconductor Corp
TRIP Tripadvisor Inc
RKT Rocket Companies Inc
BBVA Banco Bilbao Vizcaya Argentaria SA
F Ford Motor Co
AVLR Avalara Inc
Go


Based in China
Company profile

Innovent Biologics Inc is an investment holding company principally engaged in biopharmaceuticals. The Company and its subsidiaries are engaged in research and development of antibody and protein medicine products, sale and distribution of pharmaceutical products, and provision of consultation and research and development services. The Company's main product is Tyvyt (sintilimab injection), which is used to treat relapsed or refractory classical Hodgkin’s lymphoma. The Company's products also include adalimumab biosimilar IBI-303, which is used to treat rheumatoid arthritis, ankylosing spondylitis and psoriasis. Bevacizumab biosimilar IBI-305 is used to treat metastatic colorectal cancer and advanced, metastatic or recurrent non-small-cell lung cancer (NSCLC). Rituximab biosimilar IBI-301 is used to treat non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Its products are used in oncology, metabolic, immunology and ophthalmology diseases.

Price
Delayed
$4.67
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)

Today's volume of 0 shares is on pace to be much lighter than IVBXF's 10-day average volume of 10,693 shares.

0

Host Hotels & Resorts Inc. Stock Outperforms Competitors Despite Losses On The Day

4:58 pm ET June 16, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Host Hotels & Resorts Inc. HST shed 5.39% to $16.66 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 3.25% to 3,666.77 and Dow Jones Industrial Average DJIA falling 2.42% to 29,927.07. The stock's fall snapped a two-day winning streak. Host Hotels & Resorts Inc. closed $4.97 below its 52-week high ($21.63), which the company achieved on May 5th.

Despite its losses, the stock outperformed some of its competitors Thursday, as Pebblebrook Hotel Trust PEB fell 8.91% to $18.09, RLJ Lodging Trust RLJ fell 7.06% to $11.32, and Diamondrock Hospitality Co. DRH fell 7.90% to $8.51.true Trading volume (9.8 M) eclipsed its 50-day average volume of 9.2 M.

Data source: Dow Jones Market Data, FactSet. Data compiled June 16, 2022.

	

(END) Dow Jones Newswires

June 16, 2022 16:58 ET (20:58 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.